Literature DB >> 24444178

The first journal on human gene therapy celebrates its 25th anniversary.

James M Wilson.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24444178      PMCID： PMC3900113          DOI： 10.1089/hum.2013.2528

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  6 in total

Review 1.  Lessons learned from the clinical development and market authorization of Glybera.

Authors:  Laura M Bryant; Devin M Christopher; April R Giles; Christian Hinderer; Jesse L Rodriguez; Jenessa B Smith; Elizabeth A Traxler; Josh Tycko; Adam P Wojno; James M Wilson
Journal:  Hum Gene Ther Clin Dev       Date:  2013-06-29       Impact factor: 5.032

2.  Moving to the clinic with gene therapy through our new journal expansion, human gene therapy clinical development.

Authors:  James M Wilson
Journal:  Hum Gene Ther       Date:  2012-10-02       Impact factor: 5.695

3.  Gene therapy for lipoprotein lipase deficiency: working toward clinical application.

Authors:  Jaap Rip; Melchior C Nierman; Jeroen A Sierts; Wilma Petersen; Karin Van den Oever; Daniel Van Raalte; Colin J D Ross; Michael R Hayden; Andrew C Bakker; Paul Dijkhuizen; Wim T Hermens; Jaap Twisk; Erik Stroes; John J P Kastelein; Jan Albert Kuivenhoven; Janneke M Meulenberg
Journal:  Hum Gene Ther       Date:  2005-11       Impact factor: 5.695

4.  Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.

Authors:  Colin J D Ross; Jaap Twisk; Andrew C Bakker; Fudan Miao; Dennis Verbart; Jaap Rip; Tamara Godbey; Paul Dijkhuizen; Wim T J M C Hermens; John J P Kastelein; Jan Albert Kuivenhoven; Janneke M Meulenberg; Michael R Hayden
Journal:  Hum Gene Ther       Date:  2006-05       Impact factor: 5.695

5.  Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.

Authors:  Valerie Ferreira; Jaap Twisk; Karin Kwikkers; Eleonora Aronica; Diane Brisson; Julie Methot; Harald Petry; Daniel Gaudet
Journal:  Hum Gene Ther       Date:  2014-02-28       Impact factor: 5.695

6.  Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.

Authors:  Colin J D Ross; Jaap Twisk; Janneke M Meulenberg; Guoqing Liu; Karin van den Oever; Ewoud Moraal; Wim T Hermens; Jaap Rip; John J P Kastelein; Jan Albert Kuivenhoven; Michael R Hayden
Journal:  Hum Gene Ther       Date:  2004-09       Impact factor: 5.695
  6 in total
  1 in total

Review 1.  Emerging Therapies for Hepatocellular Carcinoma (HCC).

Authors:  Eesha Chakraborty; Devanand Sarkar
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.